| 14.38 -0.56 (-3.75%) | 10-14 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 20.72 | 1-year : | 24.2 |
| Resists | First : | 17.74 | Second : | 20.72 |
| Pivot price | 15.22  |
|||
| Supports | First : | 10.44 | Second : | 5.93 |
| MAs | MA(5) : | 15.33 |
MA(20) : | 13.21 |
| MA(100) : | 12.27 |
MA(250) : | 13.79 |
|
| MACD | MACD : | 1.5 |
Signal : | 1.5 |
| %K %D | K(14,3) : | 70.7 |
D(3) : | 76.9 |
| RSI | RSI(14): 56.5 |
|||
| 52-week | High : | 31 | Low : | 0.64 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ DRIO ] has closed above bottom band by 38.9%. Bollinger Bands are 72.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 23 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 14.79 - 14.9 | 14.9 - 14.97 |
| Low: | 13.75 - 13.88 | 13.88 - 13.99 |
| Close: | 14.19 - 14.38 | 14.38 - 14.52 |
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
Tue, 14 Oct 2025
Wall Street Analysts Predict a 42.77% Upside in DarioHealth (DRIO): Here's What You Should Know - Nasdaq
Mon, 06 Oct 2025
$50B Annual Fall Costs — DarioHealth Integrates OneStep's Smartphone Clinical-Grade Fall Risk Assessment - Stock Titan
Thu, 25 Sep 2025
Digital Health Platform DarioHealth Explores Sale After Multiple Acquisition Offers, Raises $17.5M - Stock Titan
Mon, 22 Sep 2025
$17.5 Million Capital Raise: Digital Health Leader DarioHealth Announces Strategic Stock Placement - Stock Titan
Mon, 22 Sep 2025
DarioHealth Announces $17.5 Million Private Placement of Common Stock Priced At-The-Market Under Nasdaq Rules - PR Newswire
Sun, 21 Sep 2025
DarioHealth Corp. (NASDAQ:DRIO) Stock's 42% Dive Might Signal An Opportunity But It Requires Some Scrutiny - simplywall.st
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Diagnostics & Research
|
|
| Shares Out | 6 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 18.2 (%) |
| Held by Institutions | 9.9 (%) |
| Shares Short | 236 (K) |
| Shares Short P.Month | 163 (K) |
| EPS | -13.4 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 28.13 |
| Profit Margin | -162.8 % |
| Operating Margin | -171.4 % |
| Return on Assets (ttm) | -22.6 % |
| Return on Equity (ttm) | -67 % |
| Qtrly Rev. Growth | -14.2 % |
| Gross Profit (p.s.) | 3.31 |
| Sales Per Share | 4.77 |
| EBITDA (p.s.) | -6.2 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -27 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | -1.08 |
| PEG Ratio | 0 |
| Price to Book value | 0.51 |
| Price to Sales | 3.01 |
| Price to Cash Flow | -3.06 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|